Executive summary. Detection, quarantine, verification, notification, and disposition are separate steps. Each one needs an owner and a record.
Definition
Suspect and illegitimate product provisions require trading partners to investigate, handle, and in certain cases notify others about product concerns.
Contain before concluding
The first decision after a concern surfaces is containment. Stop the product moving while the team investigates, and record what was held, by whom, when, and for what reason.
Containment needs a physical or system control that prevents accidental release, plus a route for escalation. A status flag on its own holds nothing.
Make the investigation reproducible
Capture the initiating signal, product identifiers, sources consulted, trading-partner communications, and outcome. A later reviewer can then follow the decision even after staff and systems change.
Trigger notification and disposition from documented criteria. Time-sensitive decisions improvised during an incident are the ones that get second-guessed afterwards.
Frequently asked questions
Is every data mismatch an illegitimate product?
No. A mismatch is often a data-quality or association problem. It still needs controlled investigation, because the facts determine the classification and the response.
Referenced standards and further reading
- FDA: Identification of Suspect Product and Notification ↗U.S. Food and Drug Administration
Related articles
DSCSA traceability and exception handling →
DSCSA product tracing: the operational record →
Enhanced drug distribution security and serialized product data →